VISIOMED GROUP: Information relating to the total number of voting rights and the number of shares making up the share capital – 09/07/2022 at 6:00 p.m.


Paris, September 7, 2022

VISIOMED GROUP (FR0013481835 – ALVMG) publishes information relating to the total number of voting rights and the number of shares making up its share capital, in accordance with the provisions of article 223-16 of the General Regulations of the Autorité des marchés financiers .

Date

Number of actions

Number of voting rights

September 6, 2022

294 354 334

Theoretical

294 393 103

Exercisable

1

294 305 312

1

The total number of exercisable voting rights is calculated on the basis of all the theoretical voting rights minus the shares deprived of voting rights.

The number of shares created since August 2, 2022 comes from:

  • The exercise of stock warrants (BSA), 42 shares;

  • The allocation of free shares (AGA)

    [1]

    i.e. 4,936,000 shares.

About VISIOMED GROUP

Founded in 2007, VISIOMED GROUP develops and markets innovative health products and services focused on uses. Its mission: to put innovation at the service of the health of all, starting from the needs of each one. BewellConnect®, its connected health subsidiary, today concentrates all the know-how of VISIOMED GROUP in terms of e-health for the general public as well as for players in the world of health with a complete ecosystem of solutions that improve prevention. , treatment and medical follow-up. It has developed and markets in particular

VisioCheck®

the 1

time

mobile and connected teleconsultation station weighing less than 300 grams.

In August 2021, VISIOMED GROUP acquired

Smart Salem

(smartsalem.ae), the only medical center digitized and accredited by the Dubai Ministry of Health (DHA) as well as the General Directorate of Residence and Foreign Affairs (GDRFA) in the United Arab Emirates.

Based in Paris, VISIOMED GROUP is listed on Euronext Growth (ALVMG). More information on visiomed.fr, smartsalem.ae and www.bewell-connect.com.

CONTACTS

Jérôme FABREGUETTES-LEIB

Fatou-Kine N’DIAYE

Investor Relations

Financial Press Relations

[email protected]

[email protected]

Phone: 01 53 67 36 78

Tel: 01 53 67 36 34

© Visiomed Group SA 2021. The brands mentioned are the property of their respective authors. Reproduction prohibited, even partial, without prior authorization.


[1]

i.e. all the shares to be issued under the free share allocation plan of August 31, 2021 (see 1.5.4. of the Notes to the consolidated financial statements as of December 31, 2021 included in the 2021 Annual Financial Report)


This post has the “? Actusnews SECURITY MASTER” service.


– SECURITY MASTER Key:

m52dY5ZnaGbHy26cl8ibmWdmaGqXl5TFbpeXlWmeapmbmXKRxmhmbMWaZnBnlmdn

– To check this key:

https://www.security-master-key.com.



Regulated information:


Total number of voting rights and capital:

– Information relating to the total number of voting rights and shares making up the capital


Full and original press release in PDF format:

https://www.actusnews.com/news/76121-visiomed_cp_ddv_septembre2022.pdf

© Copyright Actusnews Wire

Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com



Source link -86